The double face of IL-1β in lung cancer.
OpenAlex 토픽 ·
Immune Response and Inflammation
Inflammasome and immune disorders
IL-33, ST2, and ILC Pathways
Interleukin (IL)-1β is known to promote lung cancer growth in both humans and mice.
APA
Cédric Rébé, Anaïs Perrichet, François Ghiringhelli (2026). The double face of IL-1β in lung cancer.. Oncoimmunology, 15(1), 2622661. https://doi.org/10.1080/2162402X.2026.2622661
MLA
Cédric Rébé, et al.. "The double face of IL-1β in lung cancer.." Oncoimmunology, vol. 15, no. 1, 2026, pp. 2622661.
PMID
41634558
Abstract
Interleukin (IL)-1β is known to promote lung cancer growth in both humans and mice. However, in the context of the current standard of care, which includes chemotherapy and immune checkpoint inhibitors, IL-1β can overcome resistance.
MeSH Terms
Lung Neoplasms; Interleukin-1beta; Humans; Animals; Mice; Drug Resistance, Neoplasm; Immune Checkpoint Inhibitors